Fennec Pharmaceuticals Inc.

FENC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Mar 16, 2026 8-K
S-8 Mar 5, 2026 FORM S-8
8-K Mar 4, 2026 8-K
4 Mar 3, 2026
4 Mar 3, 2026
144 Mar 2, 2026
8-K Feb 20, 2026 8-K
4 Feb 19, 2026
4 Feb 19, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 11, 2026
4 Feb 2, 2026
144 Feb 2, 2026
4 Feb 2, 2026
4 Feb 2, 2026
4 Jan 23, 2026
4 Jan 15, 2026
SCHEDULE 13G/A Jan 14, 2026
4 Jan 7, 2026
4 Jan 5, 2026
4 Jan 5, 2026
144 Jan 2, 2026
4 Dec 29, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
8-K Dec 9, 2025 8-K
4 Dec 5, 2025
← Newer Page 4 of 34 · 837 filings Older →